Post by SCARLETRED Holding GmbH

💥Breaking new ground: Scarletred’s AI solution “Arora” is now live in clinical routine, setting a new standard in cancer irradiation therapy and dermatology care!! 🧠Developed over a decade in close collaboration with leading medical experts like Dr. med. Richard Partl, Specialist in Radiation Oncology & Clinical R&D, Scarletred is pioneering how AI enhances clinical decision-making in dermatology and oncology. 🏥The integration of Scarletred’s AI “Arora” at LKH University Hospital Graz, marks a transformative leap in how skin and cancer conditions are analyzed and managed. The CE certified medical device system combines cutting-edge imaging, AI, and more than a decade of clinical experience to precisely measure and analyze over 3,000 skin conditions. With 40+ international patents and validation in 100+ global medical studies, Scarletred is shaping the future of clinical research, drug development, and patient care. 🌍 Discover the full story and interview with our Chief Technology Officer Stefan Schnidar in the Austrian Newspaper Kleine Zeitung 👉 https://lnkd.in/dFbZPT_y LKH-Univ. Klinikum Graz | SCARLETRED Holding GmbH | SCARLETRED Inc | Scarletred®Vision | Harald Schnidar #Scarletred #AroraAI #ClinicalAI #AIDermatology #OncologyInnovation #PrecisionMedicine #DigitalHealth #MedicalTechnology #LifeSciences #FutureOfHealthcare #Dermatology #skinimaging #clinicalresearch #clinicaltrials #biotech #biopharma